FDA-Approved Pelvic Floor Magnetic Stimulation — Without Surgery, Probes, or Undressing

The FDA-approved Kernel KN2611M Pelvic Floor Magnetic Stimulation Chair delivers 5 Tesla medical-grade magnetic field intensity to reach deep into the pelvic floor muscles (10–15 cm penetration depth), activating both Type I and Type II muscle fibers that conventional electrical stimulation simply cannot reach. Patients remain fully clothed throughout the entire treatment — no probes, no insertion, no discomfort.

Magnetic stimulation therapy for pelvic floor disorders was FDA-approved in 1998 and is published in the European Association of Urology (EAU) guidelines as a recommended nonsurgical management option for urinary incontinence, with clinical studies demonstrating an effective rate up to 96.7%.

Maximize Results: Combination Therapy Approach

To achieve the deepest muscle recovery and best clinical outcomes, leading pelvic floor specialists recommend combining multiple therapies together:

How It Works

The KN2611M uses a time-varying magnetic field to generate induced electrical currents deep within pelvic floor tissue. Unlike conventional electrical stimulation (which requires vaginal or rectal probes and only reaches surface muscles), magnetic stimulation penetrates through clothing, skin, fat, and bone to directly activate the deep musculature responsible for bladder control and organ support.

This process:

• Modulates neuromuscular excitability in the pelvic floor
• Promotes remodeling and recovery of damaged nerves
• Increases blood circulation to pelvic floor tissues
• Strengthens both Type I and Type II pelvic floor muscle fibers

Why Deep Muscle Activation Matters

The pelvic floor contains two critical types of muscle fibers:

• Type I fibers (slow-twitch, ~70% of pelvic floor muscle) — Responsible for sustained organ support and maintaining continence at rest. These endurance fibers keep the bladder, uterus, and rectum in proper position throughout the day.
• Type II fibers (fast-twitch, ~30% of pelvic floor muscle) — Responsible for rapid, powerful contractions that prevent leakage during sudden pressure increases like coughing, sneezing, laughing, or physical movement.

Conventional electrical stimulation primarily activates surface-level Type II fibers. The KN2611M’s 5T magnetic field fully activates both fiber types, including deep Type I fibers that are critical for long-term pelvic floor recovery and organ support.

Clinical Indications

• Urinary Incontinence — Stress, urge, and mixed types (male and female)
• Pelvic Organ Prolapse — Bladder, uterine, vaginal, and rectal prolapse
• Postpartum Pelvic Floor Recovery — Muscle and nerve repair after childbirth
• Pelvic Floor Pain — Chronic pelvic pain syndrome (CPPS)
• Sexual Dysfunction — Arousal disorders, vaginal laxity
• Neurogenic Bladder — Nerve-related bladder dysfunction
• Fecal Incontinence — Anal sphincter weakness

Magnetic Stimulation vs. Electrical Stimulation

Key Features

• 5 Tesla medical-grade magnetic field — Premium-grade magnetic coils, durable and long-lasting
• FDA-approved technology — Magnetic stimulation for pelvic floor disorders approved since 1998
• Completely non-invasive — No probes, no insertion, no undressing. Patients sit fully clothed
• Dual control — Operate via mobile app or wired remote controller
• Multiple built-in protocols — Pre-programmed treatment programs with customizable intensity and frequency
• Professional chair design — Ergonomic full-back chair with headrest for patient comfort during sessions
• Combination therapy ready — Integrate with biofeedback and Kegel training for enhanced clinical outcomes

Who Is This For?

• Urology and urogynecology clinics
• Physical therapy and pelvic floor rehabilitation practices
• Postpartum recovery centers
• Elder care and assisted living facilities
• Hospitals and outpatient treatment centers

What’s in the Box

• KN2611M Pelvic Floor Magnetic Stimulation Chair
• Wired Remote Controller
• Power Cable
• User Manual

Contraindications & Safety

This device should not be used by individuals with:

• Cardiac pacemakers or other implanted electronic devices
• Metal implants in the pelvic or abdominal region
• Pregnancy or suspected pregnancy
• Active urinary or reproductive tract infections or acute inflammation
• Epilepsy or cognitive function disorders
• Malignant tumors in the treatment area
• Recent pelvic surgery or active vaginal bleeding
• Severe cardiac arrhythmia

Always consult your healthcare provider before beginning any pelvic floor therapy program.

Frequently Asked Questions

How quickly will patients see results?

Most patients notice improvement within 2–3 weeks of regular treatment. Clinical protocols typically recommend 2 sessions per week for 6–8 weeks (12–16 sessions total). Many patients report significant reduction in leakage episodes after the first few sessions.

What does the treatment feel like?

Patients feel a tingling sensation and involuntary pelvic floor muscle contractions — similar to a strong Kegel exercise being performed automatically. The intensity is adjustable. Most patients describe it as comfortable and unusual but not painful. Many read, scroll their phone, or relax during the 20–30 minute session.

What is the ROI for my clinic?

At a typical charge of $300–$500 per session, the KN2611M pays for itself within 15–25 patient sessions. A single patient completing a full treatment course (12–16 sessions) generates $3,600–$8,000 in revenue. With just 2–3 patients per week, annual revenue from this device can exceed $50,000+.

Does it require staff training?

Minimal training is needed. The device has pre-programmed treatment protocols — staff simply seat the patient, select a program, and adjust intensity. No specialized certification is required to operate the device.

How long does each treatment session take?

A typical session is 20–30 minutes. Patients remain fully clothed and seated throughout. No preparation or recovery time is needed — patients can return to normal activities immediately.

Is the KN2611M FDA approved?

Yes. Magnetic stimulation therapy for pelvic floor disorders was FDA-approved in 1998. The KN2611M uses this proven, FDA-approved technology. It is also published in the European Association of Urology (EAU) guidelines as a recommended nonsurgical treatment for urinary incontinence.

What maintenance is required?

The KN2611M uses premium-grade magnetic coils designed for heavy clinical use. No consumables, replacement parts, or regular maintenance are required. Simply wipe the chair surface between patients.

14-Day Return Policy

• Customers may return eligible products within 14 days of delivery for a refund or exchange.
• For hygiene and safety reasons, opened or used products cannot be returned unless defective or faulty.
• A 20% restocking fee applies to all returns except defective. We will repair, replace, or refund defective items free of charge.
• For full details, please refer to Return Policy under the Warranty tab.